Growth Metrics

cbdMD (YCBD) Asset Writedowns and Impairment (2017 - 2024)

cbdMD's Asset Writedowns and Impairment history spans 8 years, with the latest figure at $921314.0 for Q3 2024.

  • On a quarterly basis, Asset Writedowns and Impairment rose 229.87% to $921314.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $921314.0, a 424.97% increase, with the full-year FY2025 number at $365979.0, down 60.28% from a year prior.
  • Asset Writedowns and Impairment hit $921314.0 in Q3 2024 for cbdMD, up from -$709393.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for YCBD hit a ceiling of $30.8 million in Q2 2022 and a floor of -$49.0 million in Q3 2022.
  • Historically, Asset Writedowns and Impairment has averaged -$2.0 million across 5 years, with a median of $684284.5 in 2020.
  • Biggest five-year swings in Asset Writedowns and Impairment: plummeted 7401.1% in 2022 and later skyrocketed 229.87% in 2024.
  • Tracing YCBD's Asset Writedowns and Impairment over 5 years: stood at -$526628.0 in 2020, then soared by 227.33% to $670580.0 in 2021, then skyrocketed by 31.96% to $884892.0 in 2022, then crashed by 180.17% to -$709393.0 in 2023, then skyrocketed by 229.87% to $921314.0 in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for YCBD at $921314.0 in Q3 2024, -$709393.0 in Q3 2023, and $884892.0 in Q4 2022.